Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Adam Tai-Chi Cheuk"'
Autor:
Meijie Tian, Jun S. Wei, Adam Tai-Chi Cheuk, David Milewski, Zhongmei Zhang, Yong Yean Kim, Hsien-Chao Chou, Can Liu, Sherif Badr, Eleanor G. Pope, Abdelrahman Rahmy, Jerry T. Wu, Michael C. Kelly, Xinyu Wen, Javed Khan
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract Chimeric antigen receptor (CAR) T-cells targeting Fibroblast Growth Factor Receptor 4 (FGFR4), a highly expressed surface tyrosine receptor in rhabdomyosarcoma (RMS), are already in the clinical phase of development, but tumour heterogeneity
Externí odkaz:
https://doaj.org/article/a3964d3bf8e04e298aea51cf07822727
Autor:
Katherine E. Masih, Rebecca A Gardner, Hsien-Chao Chou, Abdalla Abdelmaksoud, Young K. Song, Luca Mariani, Vineela Gangalapudi, Berkley E. Gryder, Ashley Lauren Wilson, Serifat O. Adebola, Benjamin Z. Stanton, Chaoyu Wang, David Milewski, Yong Yean Kim, Meijie Tian, Adam Tai-Chi Cheuk, Xinyu Wen, Yue Zhang, Gregoire Altan-Bonnet, Michael C. Kelly, Jun S. Wei, Martha L. Bulyk, Michael C Jensen, Rimas J Orentas, Javed Khan
Publikováno v:
Blood advances.
CD19 CAR T-cell therapy (CD19-CAR) has changed the treatment landscape and outcomes for patients with pre-B cell acute lymphoblastic leukemia (B-ALL). Unfortunately, primary non-response (PNR), sustained CD19+ disease and concurrent expansion of CD19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e586ae7f1c21d0384d13c04a13520c88
https://pubmed.ncbi.nlm.nih.gov/36607839
https://pubmed.ncbi.nlm.nih.gov/36607839
Autor:
Adam Tai Chi Cheuk, Meijie Tian, Nityashree Shivaprasad, Steven Highfill, David Milewski, G Tom Brown, Peter Azorsa, Dina Schneider, Berkley Gryder, Jun S Wei, Young Kwok Song, Hsien-Chao Chou, Jerry Wu, Joon-Yong Chung, Brian Belyea, Corinne Linardic, Stephen M Hewitt, Boro Dropulic, Rimas Orentas, Javed Khan
Publikováno v:
Cancer Research. 82:LB213-LB213
Rhabdomyosarcoma (RMS) is an aggressive soft tissue sarcoma originating from skeletal muscle in children and adolescent young adults. Despite multi-modal aggressive therapies, relapsed, refractory or metastatic rhabdomyosarcoma remains a lethal disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95a53945457d6454e737a92bbbbbc173
https://doi.org/10.1158/1538-7445.am2022-lb213
https://doi.org/10.1158/1538-7445.am2022-lb213
Autor:
Meijie Tian, Adam Tai-Chi Cheuk, Yong Song, Sivasish Sindiri, Nan Li, Christopher M. Dower, Mitchell Ho, Bradley St Croix, Javed Khan
Publikováno v:
Cancer Research. 80:5871-5871
Background: Neuroblastoma (NB) is the most common extra-cranial solid cancer in children. Although multimodal therapies with differentiating agents and immunotherapy with anti-GD2 antibody and GM-CSF have shown promising results, it remains deadly in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8f6d23759b8d51c73dc6b67f2d05482
https://doi.org/10.1158/1538-7445.am2020-5871
https://doi.org/10.1158/1538-7445.am2020-5871